Table 2.
Univariable and multivariable logistic analysis of the clinical parameters
| Parameters | Univariable analysis OR (95%CI) |
P-value | Multivariable analysis OR (95%CI) |
P-value |
|---|---|---|---|---|
| Age | ||||
| ≤ 60 (n = 77) | 1 [Reference] | NA | 1 [Reference] | NA |
| > 60 (n = 29) | 3.320 (1.309–8.417) | 0.011 | 3.784 (1.429–10.018) | 0.007 |
| Sex | ||||
| Male(n = 72) | 1 [Reference] | NA | - | - |
| Female(n = 34) | 1.064 (0.470–2.408) | 0.881 | - | - |
| Location (cm) | ||||
| ≤ 5(n = 64) | 1 [Reference] | NA | - | - |
| 5–10(n = 42) | 1.211(0.555–2.642) | 0.631 | - | - |
| Size (cm) | ||||
| ≤ 5(n = 81) | 1 [Reference] | NA | - | - |
| > 5(n = 25) | 1.537(0.618–3.824) | 0.355 | - | - |
| Clinical stage | ||||
| II (n = 6) | 1 [Reference] | NA | 1 [Reference] | NA |
| III (n = 80) | 4.000(0,575-27.819) | 0.161 | 6.130 (0.783–47.995) | 0.084 |
| IV (n = 20) | 4.889(1.501–15.924) | 0.008 | 5.459 (1.626–18.328) | 0.006 |
| T stage | ||||
| T1 − 2(n = 8) | 1 [Reference] | NA | - | - |
| T3 − 4(n = 98) | 1.884(0.427–8.321) | 0.403 | - | - |
| N stage | ||||
| N0(n = 23) | 1 [Reference] | NA | - | - |
| N+(n = 83) | 1.231(0.488–3.103) | 0.660 | - | - |
| Distant-metastasis | ||||
| No(n = 86) | 1 [Reference] | NA | - | - |
| Yes(n = 20) | 4.821(1.489–15.610) | 0.009 | - | - |
| CEA (ng/ml) | ||||
| ≤ 5(n = 49) | 1 [Reference] | NA | - | - |
| > 5(n = 57) | 1.242(0.578–2.669) | 0.579 | - | - |
| CA199 (ng/ml) | ||||
| ≤ 35(n = 81) | 1 [Reference] | NA | - | - |
| > 35(n = 25) | 1.006(0.410–2.468) | 0.990 | - | - |
| CA242 (U/ml) | ||||
| ≤ 20(n = 70) | 1 [Reference] | NA | - | - |
| > 20(n = 36) | 1.025(0.394–2.667) | 0.960 | - | - |
OR: odds ratio; 95%CI: 95% confidence intervals; NA: not applicable. Data in brackets are the 95% confidence intervals, and data outside brackets are the odds ratio. Statistical significance was demonstrated by P < 0.05